NITYR (Cycle Pharmaceuticals Ltd.)
Welcome to the PulseAid listing for the NITYR drug offered from Cycle Pharmaceuticals Ltd.. This 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC],Hydroxyphenylpyruvate Dioxygenase Inhibitors [MoA],Cytochrome P450 2C9 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Cycle Pharmaceuticals Ltd. |
NON-PROPRIETARY NAME: | Nitisinone |
SUBSTANCE NAME: | NITISINONE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC],Hydroxyphenylpyruvate Dioxygenase Inhibitors [MoA],Cytochrome P450 2C9 Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2017-07-26 |
END MARKETING DATE: | 0000-00-00 |
NITYR HUMAN PRESCRIPTION DRUG Details:
Item Description | NITYR from Cycle Pharmaceuticals Ltd. |
LABELER NAME: | Cycle Pharmaceuticals Ltd. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10(mg/1) |
START MARKETING DATE: | 2017-07-26 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 70709-000_759533f6-e30f-4b1d-a17f-9d0f681d671c |
PRODUCT NDC: | 70709-000 |
APPLICATION NUMBER: | NDA209449 |
Other NITISINONE Pharmaceutical Manufacturers / Labelers: